To the Editor,

Molecular mimicry has been proposed as a cause of the autoimmune phenomena observed in COVID-19 \[[@bb0005], [@bb0010], [@bb0015], [@bb0020]\], the syndrome associated with the infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Lucchese and Flöel \[[@bb0020]\] have recently reported three human proteins (namely DAB1, AIFM, and SURF1, as catalogued at [www.uniprot.org](http://www.uniprot.org){#ir0040}) -- that are present in neurons of the respiratory pacemaker in the brainstem -- that share potentially antigenic epitopes with SARS-CoV-2, as shown by in silico analysis.

Particularly, they postulated that damage to the brainstem pacemaker may contribute to respiratory failure in COVID-19 as a consequence of molecular mimicry between neuronal and viral proteins, in turn causing the clinical dissociation between well-preserved lung mechanics and severity of hypoxemia.

Here, we would like to direct attention to some features of COVID-19 -- such as anosmia, leukopenia, and multi-organ failure brought about by vascular damage -- that could also be the consequence of molecular mimicry phenomena ([Table 1](#t0005){ref-type="table"} ).Table 1Peptides of immunologic relevance shared between SARS-CoV-2 and human proteins.Table 1Shared ≥6 mer (amino acids)SARS-CoV-2 proteinHuman proteinPutative Epitopes \[NCBI Reference, SARS-CoV-2\]Localization of human protein \[predicted by [uniprot.org](http://uniprot.org){#ir0005}\]IIFWFSLORF7bOR7D4 \[[Q8NG98](uniprotkb:Q8NG98){#ir0010}\]LVLIML**IIFWFSL**ELQ \[[YP_009725318.1](https://www.ncbi.nlm.nih.gov/protein/YP_009725318.1){#ir0015}\]**Cellular**: olfactory receptor.\
**Subcellular**: plasma membrane.VVNAANORF1abPARP9 \[[Q8IXQ6](uniprotkb:Q8IXQ6){#ir0020}\]**VVNAAN**VYLKHGGGVAG \[[YP_009724389.1](https://www.ncbi.nlm.nih.gov/protein/YP_009724389.1){#ir0025}\]**Cellular**: B cells; macrophage. **Subcellular**: cytosol, nucleus.SSRSSSRNucleocapsid phosphor-proteinSLC12A6 \[[Q8NG98](uniprotkb:Q8NG98){#ir0030}\]**SSRSSSR**SRNSSRNSTP \[[YP_009724397](https://www.ncbi.nlm.nih.gov/protein/YP_009724397){#ir0035}\]**Cellular**: endothelial cells; heart; brain; kidney; liver; lung. **Subcellular**: plasma membrane.

Observations {#s0005}
============

1.Odorant Receptor 7D4 (OR7D4) is one of the most important odorant receptors on the plasma membrane of olfactory sensory neurons, responding to sex steroid-derived odours, e.g., androstenone and androstadienone \[[@bb0025]\]. Its alterations have been associated with anxiety and depression \[[@bb0030]\].2.Poly (ADP-Ribose) Polymerase Family Member 9 (PARP9), also known as mono-ADP-ribosyltransferase (ARTD)-9, is a protein involved in differentiation and function of immune cells such as B lymphocytes \[[@bb0035]\] and macrophages \[[@bb0040]\].3.Solute Carrier Family 12 Member 6 (SLC12A6) is a member of the K---Cl cotransporters (KCC), integral membrane proteins that lower intracellular chloride concentrations \[[@bb0045]\]. Alternative splicing in its gene results in multiple transcript variants encoding different isoforms, the most important one being KCC3 \[[@bb0050]\]. The latter has been found in endothelial cells of various organs, including vessels, heart, brain, kidney, liver, and lung \[[@bb0055]\].

Working hypothesis {#s0010}
==================

We hypothesize that anosmia, leukopenia, and vascular damage with multi-organ damage are associated with molecular mimicry of the following proteins:

OR7D4: Anosmia. It could also be implicated in the mood disorders observed in these patients.

PARP9: Leukopenia. It could be implicated in plaque destabilization in patients with atherosclerosis.

SLC12A6: Vascular damage, in turn inducing thrombosis, disseminated intravascular coagulation, and multiorgan failure. It could also induce Kawasaki vasculitis. Interestingly, the shared epitope SSRSSSR in SLC12A6 ([Table 1](#t0005){ref-type="table"}) was found to be highly immunogenic by SVMTriP (<http://sysbio.unl.edu/SVMTriP/>), a tool used to predict protein surface regions that are preferentially recognized by antibodies (i.e., antigenic epitopes), that is helping in the design of vaccine components \[[@bb0060]\].

Although plasma membrane localization has been demonstrated only for OR7D4 and SLC12A6, we cannot exclude that, after cell stress, post-translational modifications could induce PARP9 trafficking to plasma membrane and its exposure on the cell surface, as for other intracellular proteins \[[@bb0065]\]. Other studies, including the analysis of anatomical specimens from autopsies of subjects who died from severe forms of COVID-19, are necessary to verify these predictions.
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